Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SAMRAT PHARMA PROCTER & GAMBLE HEALTH SAMRAT PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 4,683.0 34.5 13,586.1% View Chart
P/BV x 1.6 10.5 15.5% View Chart
Dividend Yield % 0.3 2.0 14.9%  

Financials

 SAMRAT PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    SAMRAT PHARMA
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
SAMRAT PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1,2505,366 23.3%   
Low Rs3323,883 8.6%   
Sales per share (Unadj.) Rs1,005.3740.7 135.7%  
Earnings per share (Unadj.) Rs53.8138.2 38.9%  
Cash flow per share (Unadj.) Rs55.9155.2 36.0%  
Dividends per share (Unadj.) Rs1.0095.00 1.1%  
Avg Dividend yield %0.12.1 6.2%  
Book value per share (Unadj.) Rs204.3447.6 45.7%  
Shares outstanding (eoy) m3.0916.60 18.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.86.2 12.6%   
Avg P/E ratio x14.733.5 43.9%  
P/CF ratio (eoy) x14.129.8 47.5%  
Price / Book Value ratio x3.910.3 37.5%  
Dividend payout %1.968.7 2.7%   
Avg Mkt Cap Rs m2,44476,761 3.2%   
No. of employees `000NANA-   
Total wages/salary Rs m112,062 0.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,10612,296 25.3%  
Other income Rs m5184 2.6%   
Total revenues Rs m3,11112,480 24.9%   
Gross profit Rs m2393,247 7.4%  
Depreciation Rs m6281 2.3%   
Interest Rs m128 160.0%   
Profit before tax Rs m2253,142 7.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m59847 7.0%   
Profit after tax Rs m1662,295 7.2%  
Gross profit margin %7.726.4 29.2%  
Effective tax rate %26.227.0 97.1%   
Net profit margin %5.418.7 28.7%  
BALANCE SHEET DATA
Current assets Rs m98611,713 8.4%   
Current liabilities Rs m5286,791 7.8%   
Net working cap to sales %14.840.0 36.9%  
Current ratio x1.91.7 108.4%  
Inventory Days Days8263 3.1%  
Debtors Days Days602343 175.3%  
Net fixed assets Rs m17510,617 1.7%   
Share capital Rs m31166 18.6%   
"Free" reserves Rs m6017,265 8.3%   
Net worth Rs m6317,431 8.5%   
Long term debt Rs m00-   
Total assets Rs m1,16222,330 5.2%  
Interest coverage x19.3409.1 4.7%   
Debt to equity ratio x00-  
Sales to assets ratio x2.70.6 485.7%   
Return on assets %15.410.3 149.1%  
Return on equity %26.330.9 85.3%  
Return on capital %37.642.4 88.8%  
Exports to sales %4.10-   
Imports to sales %83.313.1 637.8%   
Exports (fob) Rs m127NA-   
Imports (cif) Rs m2,5871,605 161.1%   
Fx inflow Rs m1271,465 8.7%   
Fx outflow Rs m2,5871,605 161.1%   
Net fx Rs m-2,460-140 1,754.5%   
CASH FLOW
From Operations Rs m-942,360 -4.0%  
From Investments Rs m-30-215 14.0%  
From Financial Activity Rs m96-985 -9.7%  
Net Cashflow Rs m-281,160 -2.5%  

Share Holding

Indian Promoters % 48.6 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 3.2 20.3 16.0%  
FIIs % 0.0 7.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 51.4 48.2 106.6%  
Shareholders   8,065 56,730 14.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SAMRAT PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SAMRAT PHARMA vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SAMRAT PHARMA vs Procter & Gamble Health Share Price Performance

Period SAMRAT PHARMA Procter & Gamble Health S&P BSE HEALTHCARE
1-Day -1.87% -0.55% 1.18%
1-Month -10.12% -7.47% -0.75%
1-Year -2.44% -3.02% 61.82%
3-Year CAGR 34.42% -9.12% 18.16%
5-Year CAGR 38.09% 5.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the SAMRAT PHARMA share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of SAMRAT PHARMA hold a 48.6% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SAMRAT PHARMA and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, SAMRAT PHARMA paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 1.9%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of SAMRAT PHARMA, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.